Macrophages in the reticuloendothelial system inhibit early induction stages of mouse apolipoprotein A-II amyloidosis
Macrophages in the reticuloendothelial system inhibit early induction stages of mouse apolipoprotein A-II amyloidosis
复制标题
网状内皮系统中的巨噬细胞抑制小鼠载脂蛋白 A-II 淀粉样变性的早期诱导阶段
DOI:
10.1080/13506129.2022.2153667
复制
发表时间:
2022
期刊:
影响因子:
5.5
通讯作者:
Higuchi Keiichi
中科院分区:
文献类型:
--
作者:
Miyahara Hiroki;Dai Jian;Li Ying;Cui Xiaoran;Takeuchi Hibiki;Hachiya Naomi;Kametani Fuyuki;Yazaki Masahide;Mori Masayuki;Higuchi Keiichi
Amyloidosis refers to a group of degenerative diseases that are characterized by the deposition of misfolded protein fibrils in various organs. Deposited amyloid may be removed by a phagocyte-dependent innate immune system; however, the precise mechanisms during disease progression remain unclear. We herein investigated the properties of macrophages that contribute to amyloid degradation and disease progression using inducible apolipoprotein A-II amyloidosis model mice. Intravenously injected AApoAII amyloid was efficiently engulfed by reticuloendothelial macrophages in the liver and spleen and disappeared by 24 h. While cultured murine macrophages degraded AApoAIIviathe endosomal-lysosomal pathway, AApoAII fibrils reduced cell viability and phagocytic capacity. Furthermore, the depletion of reticuloendothelial macrophages before the induction of AApoAII markedly increased hepatic and splenic AApoAII deposition. These results highlight the physiological role of reticuloendothelial macrophages in the early stages of pathogenesis and suggest the maintenance of phagocytic integrity as a therapeutic strategy to inhibit disease progression.